Published in J Natl Cancer Inst on March 01, 1978
Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. Infect Immun (1978) 0.97
Influence of the bursa of Fabricius on the pathogenesis of Marek's disease. Infect Immun (1981) 0.82
Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin. Am J Pathol (1981) 0.76
Improvements to the SMO algorithm for SVM regression. IEEE Trans Neural Netw (2000) 2.58
Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses (1991) 2.52
Virus-induced atherosclerosis. J Exp Med (1978) 2.32
Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis (1970) 2.03
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol (1979) 1.82
Marek's disease--a model for herpesvirus oncology. Crit Rev Microbiol (1986) 1.73
Localization of viral antigen in chickens infected with Marek's disease herpesvirus. J Natl Cancer Inst (1969) 1.65
Importance of extension and standardization of laboratory tests for the identification and classification of mycoplasma. Ann N Y Acad Sci (1967) 1.48
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature (1991) 1.47
Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. Gastroenterology (2001) 1.45
Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis (1972) 1.40
Characterization and classification of bovine mycoplasma. Cornell Vet (1971) 1.40
Virulent HIV strains, chimpanzees, and trial vaccines. Science (1999) 1.40
Pathogenesis of rotavirus infection in various age groups of chickens and turkeys: pathology. Am J Vet Res (1987) 1.37
Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol (1986) 1.29
The practical application of immunofluorescence (agar block technic) for the identification of Mycoplasma. Cornell Vet (1971) 1.27
A hypervariable region in VP1 of chicken infectious anemia virus mediates rate of spread and cell tropism in tissue culture. J Virol (1996) 1.26
Characterisation of two highly oncogenic strains of Marek's disease virus. Avian Pathol (1982) 1.24
Recommendations on nomenclature of the order Mycoplasmatales. Science (1967) 1.24
An AIDS-like condition induced in baboons by HIV-2. Science (1994) 1.22
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J Infect Dis (1996) 1.20
Herpesvirus-induced atherosclerosis in chickens. Fed Proc (1983) 1.17
Marek's disease: application of immunofluorescence for detection of antigen and antibody. Am J Vet Res (1970) 1.16
Viral antigen, virus particles, and infectivity of tissues from chickens with Marek's disease. J Natl Cancer Inst (1970) 1.15
Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J Virol (1991) 1.15
Effects of passive antibody on early pathogenesis of Marek's disease. Infect Immun (1972) 1.14
Characterization of an apparently nononcogenic Marek's disease virus. J Natl Cancer Inst (1978) 1.13
Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines. Infect Immun (1981) 1.13
In vitro isolation, propagation, and characterization of duck hepatitis virus type III. Avian Dis (1980) 1.13
Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas. Int J Cancer (1978) 1.11
Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol (2005) 1.11
In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes. Infect Immun (1979) 1.09
Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys. Appl Microbiol (1970) 1.08
Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am J Pathol (1981) 1.08
Influence of age at exposure on the pathogenesis of Marek's disease. J Natl Cancer Inst (1973) 1.07
Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retroviruses (1994) 1.06
Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis (1992) 1.04
Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells. J Biol Chem (1985) 1.03
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. AIDS (1995) 1.03
Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J Natl Cancer Inst (1983) 1.03
Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology (2000) 1.02
The contribution of feathers in the spread of chicken anemia virus. Virus Res (2008) 1.02
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
Identification of the chicken anemia agent, reproduction of the disease, and serological survey in the United States. Avian Dis (1990) 1.01
Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am J Vet Res (1979) 1.01
Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG. AIDS Res Hum Retroviruses (1992) 1.01
Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int J Cancer (1984) 0.99
Comparative effects of host and viral factors on early pathogenesis of Marek's disease. Infect Immun (1977) 0.98
Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol (2000) 0.97
Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. Infect Immun (1978) 0.97
Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance. Poult Sci (1981) 0.97
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc Natl Acad Sci U S A (1999) 0.96
Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology (1996) 0.96
Disappearance of atrial natriuretic factor from circulation in the rat. Peptides (1986) 0.96
Two distinct alpha beta T-cell lineages can be distinguished by the differential usage of T-cell receptor V beta gene segments. Proc Natl Acad Sci U S A (1991) 0.95
Functional and biochemical characterizations of avian T lymphocyte antigens identified by monoclonal antibodies. Eur J Immunol (1988) 0.95
Common garden experiment reveals pathogen isolate but no host genetic diversity effect on the dynamics of an emerging wildlife disease. J Evol Biol (2010) 0.94
Fowl Immunoglobulins: Quantitation in Birds Genetically Resistant and Susceptible to Marek's Disease. Infect Immun (1975) 0.94
Surface antigens on Marek's disease lymphoblastoid tumor cell lines. J Natl Cancer Inst (1982) 0.94
Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens. J Natl Cancer Inst (1978) 0.94
Detection of duck enteritis virus by polymerase chain reaction. Avian Dis (1998) 0.93
Indications of immunodepression in chickens infected with various strains of Marek's disease virus. Avian Dis (1988) 0.93
Papovavirus infection in hand-fed parrots: virus isolation and pathology. Avian Dis (1987) 0.93
CD8+ cells from HIV-2-infected baboons control HIV replication. AIDS (1997) 0.93
Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. Am Heart J (1999) 0.93
Isolation and characterization of avian rotaviruses. Avian Dis (1985) 0.92
Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis (2002) 0.92
Adenovirus vectored vaccines. Dev Biol Stand (1994) 0.92
Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J Natl Cancer Inst (1973) 0.92
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen. Hum Gene Ther (1998) 0.92
Pathogenesis of infection with attenuated Marek's disease virus strains. Avian Pathol (1985) 0.91
HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clin Immunol Immunopathol (1992) 0.91
Survival and disinfection of Marek's disease virus and the effectiveness of filters in preventing airborne dissemination. Poult Sci (1973) 0.91
Use of 51Cr release to measure the cytotoxic effects of staphylococcal leukocidin and toxin neutralization on bovine leukocytes. J Clin Microbiol (1986) 0.91
Characterization of proteins of chicken infectious anemia virus with monoclonal antibodies. Avian Dis (1992) 0.91
Some characteristics of cell-free preparations of Marek's disease virus. Avian Dis (1971) 0.91
Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res (1985) 0.91